Author details

Full Name

Mien-Chie Hung

Affiliation

ORCID

Career Start Year

1977

Papers

746

H Index

142

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37492703	ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer.		2023
37647772	Gasdermins and cancers.		2023
37642993	The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2.		2023
37793852	PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.	J Immunother Cancer	2023
37781042	Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity.		2023
37416781	Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation.	Int J Biol Sci	2023
36973285	Rewired m<sup>6</sup>A epitranscriptomic networks link mutant p53 to neoplastic transformation.	Nat Commun	2023
37214681	Evaluation of <sup>89</sup>Zr-Labeled Anti-PD-L1 Monoclonal Antibodies Using DFO and Novel HOPO Analogues as Chelating Agents for Immuno-PET.	ACS Omega	2023
37034222	IRG1/Itaconate induces metabolic reprogramming to suppress ER-positive breast cancer cell growth.		2023
36778120	Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity.		2023
37085943	Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics.		2023
36774302	Immune checkpoint blockades therapy of melanoma.		2023
37274180	Endothelial p130cas confers resistance to anti-angiogenesis therapy.	Cell Rep	2023
37146584	Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.	Cell Stem Cell	2023
37329887	Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation.	Cell Metab	2023
37074647	Detection of Gasdermin C-Mediated Cancer Cell Pyroptosis.		2023
37183821	RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.		2023
36622753	EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression.		2023
37178919	Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma.		2023
36863689	Disruption of SLFN11 Deficiency-Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti-PD-1 Therapy Efficacy in Hepatocellular Carcinoma.		2023
37168336	Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.	Am J Cancer Res	2023
36724291	Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusion.	Sci Adv	2023
35101449	Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2.	J Biol Chem	2022
35974014	DNA damage-induced paraspeckle formation enhances DNA repair and tumor radioresistance by recruiting ribosomal protein P0.	Cell Death and Disease	2022
35530286	Targeting 2-oxoglutarate dehydrogenase for cancer treatment.	American Journal of Cancer Research (discontinued)	2022
35530278	Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates.	American Journal of Cancer Research (discontinued)	2022
36304510	A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma.	Journal of Clinical and Translational Hepatology	2022
35968340	Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2.	American Journal of Cancer Research (discontinued)	2022
35588146	Prospects of the potential strategies to improve the efficacy of anti-PD-1/PD-L1 therapy.	Clinical and Translational Medicine	2022
35385574	Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function.	Cancer Res	2022
35894128	Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.	Journal of Food Biochemistry	2022
36284291	Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors.	Journal of Biomedical Science	2022
35693073	PD-L1 deficiency sensitizes tumor cells to DNA-PK inhibition and enhances cGAS-STING activation.	American Journal of Cancer Research (discontinued)	2022
35637074	From polyploidy to polyploidy reversal: its role in normal and disease states.	Trends in Genetics	2022
35874955	Natural tannins as anti-SARS-CoV-2 compounds.	International Journal of Biological Sciences	2022
35874948	Prospects of Coffee Leaf against SARS-CoV-2 Infection.	International Journal of Biological Sciences	2022
35687697	ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.	Sci Immunol	2022
35489965	Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)].	Journal of Hepatology	2022
35732127	Endothelial p130cas confers resistance to anti-angiogenesis therapy.	Cell Rep	2022
35551189	MRNIP condensates promote DNA double-strand break sensing and end resection.	Nature Communications	2022
35412907	Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.	Proc Natl Acad Sci U S A	2022
35860009	Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis.	Molecular Therapy - Oncolytics	2022
36322628	Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.	Sci Transl Med	2022
36119827	Snail induces dormancy in disseminated luminal type A breast cancer through Src inhibition.	American Journal of Cancer Research (discontinued)	2022
36381327	Structural insights into EphA4 unconventional activation from prediction of the EphA4 and its complex with ribonuclease 1.	American Journal of Cancer Research (discontinued)	2022
36381324	Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis.	American Journal of Cancer Research (discontinued)	2022
36253486	Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.	Nat Cancer	2022
36116159	GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.	Redox Biology	2022
36050478	Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis.	Cellular and Molecular Immunology	2022
36504903	Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinoma.		2022